Synapse - Hematologic Malignancies, Division of

Results (13379)

Phase I dose-escalation study of AGS-PSCA, an anti-PSCA human antibody, in castration-resistant prostate cancer

Meeting Abstract

Carducci, M. A.; Morris, M. J.; Eisenberger, M. A.; Pili, R.; Denmeade, S. R.; Slovin, S. F.; Kelsen, M.; Jacobovits, A.; Vincent, M.; Scher, H. I.
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies

Meeting Abstract

Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; more...
Blood (2007)

Fulltext@MSK | Save

Validation of paxgene tubes for BCR-ABL quantitation at MMR value using 105 paired samples

Meeting Abstract

Beillard, E.; Fuller, C.; Mazanet, R.; Maslak, P.; Cortes, J.; Heinrich, M.; Druker, B.; Galderisi, C.
Journal of Molecular Diagnostics (2007)

Fulltext@MSK | Save

The dose-match interaction in umbilical cord blood (UCB) transplantation: An analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy